Supplementary Figures

Supplementary Figure 1 Comparison of tobramycin released from solvent-cast PCL/PEG coated allograft micron-sized particulate: A) the closed circles represent the inclusion of 35% PEG into the formulation with PCL and a 10% w/w loading of tobramycin, while the open circles represent the inclusion of 45% PEG into the same formulation. B) In vitro zone of inhibition assay against E. coli cultures. No significant differences between the two different feedstock concentrations of PEG porogen are seen.

Department of Pharmaceutics and Pharmaceutical Chemistry 30 S 2000 E RM 301 Salt Lake City, Utah 84112-5820 Phone (801) 585-9196 Fax (801) 581-3674